Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease.

Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group.

Mayo Clin Proc. 2019 Aug 28. pii: S0025-6196(19)30273-3. doi: 10.1016/j.mayocp.2019.02.023. [Epub ahead of print] Review.

PMID:
31472931
2.

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.

Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group.

Haematologica. 2019 Apr 19. pii: haematol.2019.219626. doi: 10.3324/haematol.2019.219626. [Epub ahead of print]

3.

A revised biosynthetic pathway for the cofactor F420 in prokaryotes.

Bashiri G, Antoney J, Jirgis ENM, Shah MV, Ney B, Copp J, Stuteley SM, Sreebhavan S, Palmer B, Middleditch M, Tokuriki N, Greening C, Scott C, Baker EN, Jackson CJ.

Nat Commun. 2019 Apr 5;10(1):1558. doi: 10.1038/s41467-019-09534-x.

4.

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.

Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS; Mayo Clinic Histiocytosis Working Group.

Blood. 2019 Apr 4;133(14):1607-1610. doi: 10.1182/blood-2018-12-893917. Epub 2019 Jan 29. No abstract available.

PMID:
30696619
5.

Treatment patterns and healthcare resource utilization in patients with FLT3-mutated and wild-type acute myeloid leukemia: A medical chart study.

Griffin JD, Yang H, Song Y, Kinrich D, Shah MV, Bui CN.

Eur J Haematol. 2019 Apr;102(4):341-350. doi: 10.1111/ejh.13205. Epub 2019 Feb 5.

PMID:
30578743
6.

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.

Shah MV, Saliba RM, Rondon G, Chen J, Soebbing D, Rus I, Alousi A, Oran B, Kebriaei P, Qazilbash M, Parmar S, Hosing C, Khouri IF, Popat UR, Champlin RE, Ciurea SO.

Bone Marrow Transplant. 2019 Apr;54(4):601-606. doi: 10.1038/s41409-018-0367-2. Epub 2018 Oct 18.

PMID:
30337700
7.

Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients.

Miller KC, Al-Kali A, Shah MV, Hogan WJ, Elliott MA, Begna KH, Gangat N, Patnaik MM, Viswanatha DS, He R, Greipp PT, Sproat LZ, Foran JM, Litzow MR, Alkhateeb HB.

Leuk Lymphoma. 2019 Apr;60(4):990-999. doi: 10.1080/10428194.2018.1509318. Epub 2018 Oct 2.

PMID:
30277111
8.

Initial Experience Using Intraoperative Magnetic Resonance Imaging During a Trans-Sulcal Tubular Retractor Approach for the Resection of Deep-Seated Brain Tumors: A Case Series.

Akbari SHA, Sylvester PT, Kulwin C, Shah MV, Somasundaram A, Kamath AA, Beaumont TL, Rich KM, Chicoine MR.

Oper Neurosurg (Hagerstown). 2019 Mar 1;16(3):292-301. doi: 10.1093/ons/opy108.

PMID:
29850853
9.

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.

Shah MV, Jorgensen JL, Saliba RM, Wang SA, Alousi AM, Andersson BS, Bashir Q, Ciurea SO, Kebriaei P, Marin D, Patel KP, Popat UR, Rezvani K, Rondon G, Shpall EJ, Champlin RE, Oran B.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1514-1520. doi: 10.1016/j.bbmt.2018.02.003. Epub 2018 Feb 12.

10.

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation.

Shah MV, Patel KP, Luthra R, Kanagal-Shamanna R, Mehrotra M, Bachegowda LS, Champlin RE, Verstovsek S, Popat UR.

Br J Haematol. 2018 Dec;183(5):831-835. doi: 10.1111/bjh.15059. Epub 2017 Dec 19. No abstract available.

PMID:
29265180
11.

Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease.

Goyal G, Shah MV, Call TG, Hook CC, Hogan WJ, Go RS.

Blood Cancer J. 2017 Dec 15;7(12):647. doi: 10.1038/s41408-017-0034-7. No abstract available.

12.

Efficacy of biological agents in the treatment of Erdheim-Chester disease.

Goyal G, Shah MV, Call TG, Litzow MR, Wolanskyj-Spinner AP, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Hook CC, Hogan WJ, Go RS.

Br J Haematol. 2018 Nov;183(3):520-524. doi: 10.1111/bjh.14997. Epub 2017 Oct 30. No abstract available.

PMID:
29082516
13.

Introduction: surgical management of skull base meningiomas.

Zada G, Başkaya MK, Shah MV.

Neurosurg Focus. 2017 Oct;43(VideoSuppl2):Intro. doi: 10.3171/2017.10.FocusVid.Intro.

PMID:
28967307
14.

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Ciurea SO, Shah MV, Saliba RM, Gaballa S, Kongtim P, Rondon G, Chen J, Wallis W, Cao K, Konopleva M, Daver N, Cortes J, Ravandi F, Alousi A, Ahmed S, Popat U, Parmar S, Bashir Q, Betul O, Hosing C, Shpall EJ, Rezvani K, Khouri IF, Kebriaei P, Champlin RE.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1232-1236. doi: 10.1016/j.bbmt.2017.09.005. Epub 2017 Sep 14.

15.

Technology that achieves the Triple Aim: an economic analysis of the BrainPath™ approach in neurosurgery.

Norton SP, Dickerson EM, Kulwin CG, Shah MV.

Clinicoecon Outcomes Res. 2017 Aug 26;9:519-523. doi: 10.2147/CEOR.S133623. eCollection 2017.

16.

HLA-mismatched bone marrow transplantation in severe aplastic anemia.

Bachegowda LS, Shah MV, Veltri LW, Tanase A, Popat U, Anderlini P, Chen J, Rondon G, Champlin RE, Ciurea SO.

Bone Marrow Transplant. 2017 Sep;52(9):1347-1348. doi: 10.1038/bmt.2017.146. Epub 2017 Jul 10. No abstract available.

PMID:
28692030
17.

Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes.

Goyal G, Shah MV, Hook CC, Wolanskyj AP, Call TG, Rech KL, Go RS.

Br J Haematol. 2018 Aug;182(4):579-581. doi: 10.1111/bjh.14818. Epub 2017 Jun 27. No abstract available.

PMID:
28653448
18.

Ictal asystole: A rare cardiac manifestation of temporal lobe epilepsy, treated with epilepsy surgery.

Ravat SH, Bhatti AA, Shah MV, Muzumdar DP, Ravat SH.

Ann Indian Acad Neurol. 2017 Jan-Mar;20(1):55-57. doi: 10.4103/0972-2327.199916.

19.

Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.

Goyal G, Shah MV, Call TG, Litzow MR, Hogan WJ, Go RS.

JAMA Oncol. 2017 Sep 1;3(9):1253-1256. doi: 10.1001/jamaoncol.2017.0041.

20.

Hospitalization Costs for Patients Undergoing Orthopedic Surgery Treated With Intravenous Acetaminophen (IV-APAP) Plus Other IV Analgesics or IV Opioid Monotherapy for Postoperative Pain.

Maiese BA, Pham AT, Shah MV, Eaddy MT, Lunacsek OE, Wan GJ.

Adv Ther. 2017 Feb;34(2):421-435. doi: 10.1007/s12325-016-0449-8. Epub 2016 Dec 10.

21.

Outcomes in transcranial microsurgery versus extended endoscopic endonasal approach for primary resection of adult craniopharyngiomas.

Wannemuehler TJ, Rubel KE, Hendricks BK, Ting JY, Payner TD, Shah MV, Cohen-Gadol AA.

Neurosurg Focus. 2016 Dec;41(6):E6.

PMID:
27903125
22.

Acid ceramidase is upregulated in AML and represents a novel therapeutic target.

Tan SF, Liu X, Fox TE, Barth BM, Sharma A, Turner SD, Awwad A, Dewey A, Doi K, Spitzer B, Shah MV, Morad SA, Desai D, Amin S, Zhu J, Liao J, Yun J, Kester M, Claxton DF, Wang HG, Cabot MC, Schuchman EH, Levine RL, Feith DJ, Loughran TP Jr.

Oncotarget. 2016 Dec 13;7(50):83208-83222. doi: 10.18632/oncotarget.13079.

23.

A population-based study of large granular lymphocyte leukemia.

Shah MV, Hook CC, Call TG, Go RS.

Blood Cancer J. 2016 Aug 5;6(8):e455. doi: 10.1038/bcj.2016.59.

24.
25.

Effect of short-term ε-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage.

Malekpour M, Kulwin C, Bohnstedt BN, Radmand G, Sethia R, Mendenhall SK, Weyhenmeyer J, Hendricks BK, Leipzig T, Payner TD, Shah MV, Scott J, DeNardo A, Sahlein D, Cohen-Gadol AA.

J Neurosurg. 2017 May;126(5):1606-1613. doi: 10.3171/2016.4.JNS152951. Epub 2016 Jun 17.

PMID:
27315025
26.

Ciliochoroidal ganglioneuroma in neurofibromatosis type 1: Report of a case and review of the literature.

Abdulkader MM, Dalesandro MF, Mendenhall SK, Shah MV, Bonnin JM.

Neuropathology. 2016 Oct;36(5):464-469. doi: 10.1111/neup.12286. Epub 2016 Mar 11. Review.

PMID:
26970398
27.

Isolated Portal Venous Hepatocellular Carcinoma.

Mutai J, Nebayosi T, Sande J, Shah MV.

J Gastrointest Cancer. 2017 Mar;48(1):80-82. doi: 10.1007/s12029-016-9805-9. No abstract available.

PMID:
26820465
28.

Minimally Invasive Transsulcal Resection of Intraventricular and Periventricular Lesions Through a Tubular Retractor System: Multicentric Experience and Results.

Eliyas JK, Glynn R, Kulwin CG, Rovin R, Young R, Alzate J, Pradilla G, Shah MV, Kassam A, Ciric I, Bailes J.

World Neurosurg. 2016 Jun;90:556-564. doi: 10.1016/j.wneu.2015.12.100. Epub 2016 Jan 22.

29.

Transport and metabolism of fumaric acid in Saccharomyces cerevisiae in aerobic glucose-limited chemostat culture.

Shah MV, van Mastrigt O, Heijnen JJ, van Gulik WM.

Yeast. 2016 Apr;33(4):145-61. doi: 10.1002/yea.3148. Epub 2016 Feb 15.

30.

Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma.

McDonald MW, Linton OR, Moore MG, Ting JY, Cohen-Gadol AA, Shah MV.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):304-11. doi: 10.1016/j.ijrobp.2015.08.011. Epub 2015 Aug 7.

PMID:
26519991
31.

Erdheim-Chester Disease.

Shah MV, Go RS.

Mayo Clin Proc. 2015 Sep;90(9):1310. doi: 10.1016/j.mayocp.2015.03.019. No abstract available.

PMID:
26355408
32.

Intracranial chordoma presenting as acute hemorrhage in a child: Case report and literature review.

Moore KA, Bohnstedt BN, Shah SU, Abdulkader MM, Bonnin JM, Ackerman LL, Shaikh KA, Kralik SF, Shah MV.

Surg Neurol Int. 2015 Apr 20;6:63. doi: 10.4103/2152-7806.155445. eCollection 2015.

33.

Posterior interhemispheric transfalcine transprecuneus approach for microsurgical resection of periatrial lesions: indications, technique, and outcomes.

Bohnstedt BN, Kulwin CG, Shah MV, Cohen-Gadol AA.

J Neurosurg. 2015 Oct;123(4):1045-54. doi: 10.3171/2015.3.JNS14847. Epub 2015 May 1.

34.

Proton therapy for atypical meningiomas.

McDonald MW, Plankenhorn DA, McMullen KP, Henderson MA, Dropcho EJ, Shah MV, Cohen-Gadol AA.

J Neurooncol. 2015 May;123(1):123-8. doi: 10.1007/s11060-015-1770-9. Epub 2015 Apr 10.

35.

EBV-positive peripheral T-cell lymphoma with extensive hemophagocytosis.

Shah MV, Go RS.

Blood. 2014 Nov 20;124(22):3329. No abstract available.

36.

Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental design.

Sharma OP, Shah MV, Parikh DC, Mehta TA.

Expert Opin Drug Deliv. 2015 Apr;12(4):513-24. doi: 10.1517/17425247.2014.944861. Epub 2014 Nov 27.

PMID:
25428196
37.

Proton therapy for reirradiation of progressive or recurrent chordoma.

McDonald MW, Linton OR, Shah MV.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1107-14. doi: 10.1016/j.ijrobp.2013.09.038.

PMID:
24267972
38.

Spinous process fixation devices for instrumented spinal fusion.

Hardenbrook M, Henn JS, Oppenheim J, Shah MV.

Surg Technol Int. 2013 Sep;23:273-82.

PMID:
24081843
39.

Impact of genetic targets on cancer therapy in acute myelogenous leukemia.

Shah MV, Barochia A, Loughran TP Jr.

Adv Exp Med Biol. 2013;779:405-37. doi: 10.1007/978-1-4614-6176-0_19. Review.

PMID:
23288651
40.

Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: a review of the literature.

Boswell KA, Wang X, Shah MV, Aapro MS.

Breast. 2012 Dec;21(6):701-6. doi: 10.1016/j.breast.2012.09.005. Epub 2012 Oct 23. Review.

PMID:
23092824
41.

Helicobacter pylori eradication: A randomised comparative trial of 7-day versus 14-day triple therapy.

Sokwala A, Shah MV, Devani S, Yonga G.

S Afr Med J. 2012 May 8;102(6 Pt 2):368-71.

PMID:
22668909
42.

Diversity and partitioning of bacterial populations within the accessory nidamental gland of the squid Euprymna scolopes.

Collins AJ, LaBarre BA, Won BS, Shah MV, Heng S, Choudhury MH, Haydar SA, Santiago J, Nyholm SV.

Appl Environ Microbiol. 2012 Jun;78(12):4200-8. doi: 10.1128/AEM.07437-11. Epub 2012 Apr 13.

43.

A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgery.

Osbun JW, Ellenbogen RG, Chesnut RM, Chin LS, Connolly PJ, Cosgrove GR, Delashaw JB Jr, Golfinos JG, Greenlee JD, Haines SJ, Jallo J, Muizelaar JP, Nanda A, Shaffrey M, Shah MV, Tew JM Jr, van Loveren HR, Weinand ME, White JA, Wilberger JE.

World Neurosurg. 2012 Nov;78(5):498-504. doi: 10.1016/j.wneu.2011.12.011. Epub 2011 Dec 10.

PMID:
22381303
44.

The role of canonical Wnt signaling in leg regeneration and metamorphosis in the red flour beetle Tribolium castaneum.

Shah MV, Namigai EK, Suzuki Y.

Mech Dev. 2011 Sep-Dec;128(7-10):342-58. doi: 10.1016/j.mod.2011.07.001. Epub 2011 Jul 23.

45.

Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia.

Liao A, Broeg K, Fox T, Tan SF, Watters R, Shah MV, Zhang LQ, Li Y, Ryland L, Yang J, Aliaga C, Dewey A, Rogers A, Loughran K, Hirsch L, Jarbadan NR, Baab KT, Liao J, Wang HG, Kester M, Desai D, Amin S, Loughran TP Jr, Liu X.

Blood. 2011 Sep 8;118(10):2793-800. doi: 10.1182/blood-2011-01-331447. Epub 2011 Jul 18.

46.

Safety and clinical findings of BiPAP utilization in children 20 kg or less for asthma exacerbations.

Williams AM, Abramo TJ, Shah MV, Miller RA, Burney-Jones C, Rooks S, Estrada C, Arnold DH.

Intensive Care Med. 2011 Aug;37(8):1338-43. doi: 10.1007/s00134-011-2238-9. Epub 2011 May 13.

PMID:
21567114
47.

Spinal surgery following organ transplantation.

Shaikh KA, Helbig GM, Shapiro SA, Shah MV, Khairi SA, Horn EM.

J Neurosurg Spine. 2011 Jun;14(6):779-84. doi: 10.3171/2011.2.SPINE10481. Epub 2011 Mar 25.

PMID:
21438655
48.

NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.

Yu J, Mitsui T, Wei M, Mao H, Butchar JP, Shah MV, Zhang J, Mishra A, Alvarez-Breckenridge C, Liu X, Liu S, Yokohama A, Trotta R, Marcucci G Jr, Benson DM, Loughran TP Jr, Tridandapani S, Caligiuri MA.

J Clin Invest. 2011 Apr;121(4):1456-70. doi: 10.1172/JCI43242.

49.

Persistent hepatitis A infection: case report.

Ngunga M, Shah MV.

East Afr Med J. 2010 Apr;87(4):174-6.

PMID:
23057294
50.

The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): I. Construct validity.

Wilde EA, McCauley SR, Kelly TM, Weyand AM, Pedroza C, Levin HS, Clifton GL, Schnelle KP, Shah MV, Moretti P.

J Neurotrauma. 2010 Jun;27(6):983-9. doi: 10.1089/neu.2009.1194.

Supplemental Content

Support Center